https://www.causaly.com/ai-platform/generative-ai-copilot https://www.causaly.com/ai-platform/knowledge-graph https://www.causaly.com/ai-platform/enterprise-data-fabric https://www.causaly.com/ai-platform/scientific-rag https://www.causaly.com/products/discover https://www.causaly.com/products/bio-graph https://www.causaly.com/products/bio-graph-api https://www.causaly.com/use-cases/target-identification-prioritization https://www.causaly.com/use-cases/biomarker-discovery https://www.causaly.com/use-cases/disease-pathophysiology https://www.causaly.com/resources/events-webinars https://www.causaly.com/resources/news https://www.causaly.com/resources/blog https://www.causaly.com/request-a-demo https://www.causaly.com/about https://www.causaly.com/contact-us https://www.causaly.com/resources https://www.causaly.com/search https://www.causaly.com/resources/downloads https://www.causaly.com/resources/case-studies https://www.causaly.com/products/pipeline-graph https://www.causaly.com/use-cases/indication-expansion https://www.causaly.com/use-cases/target-disease-association https://www.causaly.com/products/agentic-research https://www.causaly.com https://www.causaly.com/news/causaly-announces-agentic-ai-for-scientific-discovery https://www.causaly.com/news/causaly-announces-iso-27001-certification https://www.causaly.com/news/causaly-introduces-first-agentic-ai-platform-built-for-life-sciences-research-and-development https://www.causaly.com/news/causaly-launches-agentic-ai-platform-to-transform-life-sciences-r-d https://www.causaly.com/news/causaly-launches-ai-powered-competitive-intelligence-application https://www.causaly.com/news/causaly-raises-17-million-to-accelerate-biomedical-research-and-discovery-of-scientific-breakthroughs https://www.causaly.com/news/causaly-raises-5m-in-series-a-round-led-by-pentech-ventures https://www.causaly.com/news/causaly-raises-60-million-in-series-b-funding-to-catalyze-ai-powered-preclinical-discovery https://www.causaly.com/news/covid-19-causaly-partners-with-ucl-to-accelerate-coronavirus-research https://www.causaly.com/news/how-generative-ai-is-transforming-early-drug-discovery-insights-from-novartis-jeremy-jenkins-at-hariri-institute-boston https://www.causaly.com/blog/a-cios-guide-to-agent-orchestration-platforms-and-scientific-evidence-systems-in-r-d https://www.causaly.com/blog/accelerate-target-discovery-with-the-help-of-ai https://www.causaly.com/blog/agentic-ai-unlocking-deeper-insights-and-accelerating-scientific-discovery https://www.causaly.com/blog/agentification-in-biopharma-r-d-how-to-turn-workflows-into-executable-systems https://www.causaly.com/blog/ai-agent-platform-for-scientists https://www.causaly.com/blog/ai-powered-drug-discovery-identifying-safety-red-flags https://www.causaly.com/blog/aiding-drug-repurposing-investigations-with-ai https://www.causaly.com/blog/bias-starts-early-in-research-so-can-ai https://www.causaly.com/blog/biomarkers-of-treatment-response-in-liver-cancer https://www.causaly.com/blog/build-a-complete-drug-pipeline-landscape-with-causaly-competitive-intelligence https://www.causaly.com/blog/causaly-deep-research-agentic-ai https://www.causaly.com/blog/challenging-the-status-quo-a-biomarker-use-case https://www.causaly.com/blog/comparison-of-safety-biomarkers-for-chemotherapeutics https://www.causaly.com/blog/context-graphs-for-agentic-ai https://www.causaly.com/blog/eliminating-bias-with-human-centric-ai https://www.causaly.com/blog/enhance-your-search-sensitivity-with-ai-off-target-effects-of-braf https://www.causaly.com/blog/expedite-biomarker-discovery-with-human-centric-ai https://www.causaly.com/blog/exploring-biochemical-pathways-with-human-centric-ai https://www.causaly.com/blog/exploring-the-disease-pathophysiology-of-rheumatoid-arthritis https://www.causaly.com/blog/from-copilots-to-agentic-workflows-how-ai-in-r-d-changes-in-2026 https://www.causaly.com/blog/from-retrieval-to-reasoning-how-ai-can-meet-scientific-standards-in-r-d https://www.causaly.com/blog/how-automating-scientific-workflows-improves-reproducibility-in-life-sciences https://www.causaly.com/blog/how-gen-ai-is-improving-productivity-across-life-sciences-r-d-teams https://www.causaly.com/blog/how-manas-ai-uses-causaly-to-validate-targets-and-reduce-early-stage-risk https://www.causaly.com/blog/how-termination-conditions-strengthen-agentic-systems-in-r-d https://www.causaly.com/blog/introducing-agentic-research-a-new-era-for-scientific-decision-making https://www.causaly.com/blog/introducing-pipeline-graph-bring-competitive-intelligence-to-research-scientists https://www.causaly.com/blog/leveraging-ai-for-scientific-knowledge-extraction https://www.causaly.com/blog/moving-beyond-ai-answers-to-how-science-actually-gets-done- https://www.causaly.com/blog/navigating-the-biomedical-literature-insights-vs-papers https://www.causaly.com/blog/proqr-target-identification-case-study https://www.causaly.com/blog/search-by-target-class-enzyme-targets-for-celiac-disease https://www.causaly.com/blog/tackling-drug-discovery-inefficiencies-with-ai https://www.causaly.com/blog/target-based-drug-discovery-begins-with-understanding-disease-pathophysiology https://www.causaly.com/blog/target-identification-and-prioritization-ovarian-cancer https://www.causaly.com/blog/target-identification-in-prostate-cancer https://www.causaly.com/blog/the-5-dimensions-of-trustworthy-agentic-ai-in-scientific-r-d https://www.causaly.com/blog/the-agent-harness-that-makes-scientific-ai-work https://www.causaly.com/blog/the-fdas-new-guiding-principles-for-ai-in-drug-development https://www.causaly.com/blog/the-official-2024-launch-of-causaly-copilot https://www.causaly.com/blog/uncovering-the-mechanism-of-action-of-evolocumab-against-pad https://www.causaly.com/blog/unraveling-mechanisms-of-disease-pathogenesis-with-ai https://www.causaly.com/blog/why-generic-chats-fail-in-science https://www.causaly.com/blog/why-sops-are-not-enough-to-run-scientific-workflows https://www.causaly.com/events-and-webinars/agentic-ai-and-the-new-pace-of-drug-discovery https://www.causaly.com/events-and-webinars/ai-for-enhanced-biomarker-discovery https://www.causaly.com/events-and-webinars/autonomous-ai-agents-for-life-sciences https://www.causaly.com/events-and-webinars/bring-competitive-intelligence-to-your-scientific-research-causaly-webinar https://www.causaly.com/events-and-webinars/business-case-for-ai-novartis-gartner https://www.causaly.com/events-and-webinars/causaly-connect-live-2023 https://www.causaly.com/events-and-webinars/decoding-the-future-of-drug-discovery https://www.causaly.com/events-and-webinars/from-ai-to-impact-how-gpt-applications-are-accelerating-drug-discovery https://www.causaly.com/events-and-webinars/genai-for-r-d-organizations-from-experimentation-to-scale https://www.causaly.com/events-and-webinars/transforming-drug-discovery-with-llms-how-to-stay-on-top-of-the-capabilities-growth-curve https://www.causaly.com/events-and-webinars/transforming-early-stage-drug-discovery-with-llms https://www.causaly.com/events-and-webinars/unlock-a-new-way-to-research-with-ai-webinar https://www.causaly.com/downloads/benchmarking-agentic-ai-for-life-sciences https://www.causaly.com/downloads/infographic-target-discovery-in-endocrinology https://www.causaly.com/downloads/scientific-information-retrieval-system-the-foundation-of-causalys-agentic-ai-platform https://www.causaly.com/downloads/spotlight-on-biomarkers https://www.causaly.com/downloads/target-discovery-factsheet https://www.causaly.com/legal/privacy-policy https://www.causaly.com/legal/terms-of-service https://www.causaly.com/case-studies/from-4-weeks-to-1-how-causaly-cut-proposal-time-by-75-during-a-critical-disease-area-transition https://www.causaly.com/case-studies/from-complexity-to-clarity-how-a-scientist-accelerates-target-validation-with-causaly https://www.causaly.com/case-studies/how-a-top-10-pharma-company-transformed-clinical-program-evaluation-with-causaly https://www.causaly.com/case-studies/how-innate-pharma-uses-causaly-for-systematic-target-identification https://www.causaly.com/case-studies/proqr-uses-causaly-to-support-target-identification-case-study https://www.causaly.com/case-studies/unlocking-new-therapeutic-horizons-how-researchers-accelerate-drug-repurposing-with-causaly https://www.causaly.com/case-studies/using-causaly-to-accelerate-clinical-evidence-validation-for-fda-submissions